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ABSTRACT
Hip fractures are the most serious of all fragility fractures in older people of both sexes. Trips, stumbles, and falls result in fractures of
the femoral neck or trochanter, and the incidence of these two common fractures is increasing worldwide as populations age.
Although clinical risk factors and chance are important in causation, the ability of a femur to resist fracture also depends on the size
and spatial distribution of the bone, its intrinsic material properties, and the loads applied. Over the past two decades, clinical
quantitative computed tomography (QCT) studies of living volunteers have provided insight into how the femur changes with
advancing age to leave older men and women at increased risk of hip fractures. In this review, we focus on patterns of cortical bone
loss associated with hip fracture, age‐related changes in cortical bone, and the effects of drugs used to treat osteoporosis. There are
several methodologies available tomeasure cortical bone in vivo using QCT. Most techniques quantify bone density (g/cm3), mass (g),
and thickness (mm) in selected, predeﬁned or “traditional” regions of interest such as the “femoral neck” or “total hip” region. A recent
alternative approach termed “computational anatomy,” uses parametricmethods to identify systematic differences, before displaying
statistically signiﬁcant regions as color‐scaled maps of density, mass, or thickness on or within a representative femur model. This
review will highlight discoveries made using both traditional and computational anatomy methods, focusing on cortical bone of the
proximal femur. © 2014 American Society for Bone and Mineral Research.
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Introduction
Hip fractures are the most serious of all fragility fractures,leading to signiﬁcant reductions in mobility, independence,
quality of life, and increased mortality in older people of both
sexes.(1) Fractures of the proximal femur are projected to occur
worldwide in more than 6.3 million people per year by 2050.(2)
Hip fractures (which are split approximately 50:50 into cervical
and trochanteric types(3)) result from a structural failure of the
femur that is likely initiated at the material level, whereby the
load applied to the bone exceeds its load‐bearing capacity. A trip,
stumble, or fall is the cause ofmore than 90% of hip fractures, but
a minority occur spontaneously in stance.(4) Whether a femur
fractures under these loads depends on the size and spatial
distribution of bone, its intrinsic material properties and also
factors that contribute to the loads applied. Cortical bone is key
to the structural stability of whole bone, but it is important to
remember that skeletal structure is only one component of
fragility fracture risk, with clinical risk factors and chance also
playing major roles.
This review highlights discoveries made by researchers
studying individuals who have undergone clinical computed
tomography (CT) of the pelvis and hips, focusing on cortical
bone of the proximal femur and patterns of bone loss
associated with hip fracture. We also discuss important
discoveries made using clinical CT in trials and aging cohorts,
including age‐related changes in cortical bone and the effects
of drugs used to treat osteoporosis. An important justiﬁcation
for undertaking this review has been the growing consensus
that studying the determinants of speciﬁc hip fracture types in
three dimensions (principally cervical versus trochanteric) will
improve our understanding of fracture causation, prevention,
and mechanics.(5) The current clinical standard for fracture
prediction is dual‐energy X‐ray absorptiometry (DXA) of
the femoral neck, but DXA measures two‐dimensional bone
“density”—an amalgam of cortical and trabecular bone
density, structure, and bone size. Three‐dimensional (3D)
imaging modalities such as quantitative CT (QCT) can measure
cortical and trabecular compartments separately, regions that
may play independent roles in fragility fracture. 3D QCT can
also be reformatted or projected to give “DXA‐like” two‐
dimensional areal bone mineral density (aBMD) measures. In
fact, either DXA femoral neck aBMD or hip QCT measures of
the same region can now be entered into the WHO absolute
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fracture risk calculator for adults, Fracture Risk Assessment
Tool (FRAXTM).
Acquisition of Clinical CT Images For Hip
Measurements
CT scanners produce a series of thin “tomograms” or axial slices
through the body region of interest (ROI), for our purposes the
pelvis and hips. A position statement from experts in clinical
QCT has reviewed the clinical application of hip and spine CT
technology in detail.(6) Despite this International Society for
Clinical Densitometry (ICSD) consensus document, there is no
“one size ﬁts all” approach to clinical CT measurements. Table 1
shows the considerable variation in the numerous parameters
reported when acquiring the CT images for various clinical
studies. Not only will the acquisition parameters set by the CT
radiographer team inﬂuence the quality of the images attained,
but so will routine dose‐limiting of the imaging system. As an
example of the dose involved for multislice hip CT, acquiring an
image slice thickness of 1mmwill involve an approximate typical
effective dose of 3 mSV in comparison to 0.05 mSV for a DXA
acquisition, a factor which must be borne in mind when
contemplating QCT in clinical practice.(7) Scan protocol variables
such as patient positioning, X‐ray tube peak voltage (kVp), tube
current, pitch, gantry rotation speed, detector conﬁguration,
table height, and reconstruction algorithm will all affect
measurements. Indeed, a study using ex vivo spine specimens
to simulate patient repositioning found that BMD QCT precision
was 1.4% using the same scan protocol, 1.8% when permitting
some variation in the X‐ray tube current and table speed.
However, without any constraints on the clinical QCT protocol
the precision fell to 3.6% at worst.(8) Although variations in kVp
and table height can be controlled when measuring bone
density (by using a calibration phantom that is accurately
positioned in the ﬁeld of view(9)), further studies are needed to
better characterize potential sources of variation in measure-
ments, not least to help in the interpretation of multicenter
studies. For an in‐depth analysis of the technical aspects of
skeletal QCT measurements, we refer readers to a recent book
chapter that covers the physics in detail.(10)
Cortical Bone
Human bone is composed of two fundamental compartments:
cortical bone and trabecular bone.(11,12) Cortical bone makes up
approximately 80% of the skeletal mass of an adult human(13)
and is primarily found in the shaft of long bones formed as a shell
around the trabecular bone. It can withstand much greater load
than trabecular bone and deforms little before failure. In contrast,
trabecular bone can deform signiﬁcantly but will fail at a much
lower load. Even though trabecular bone cannot withstand high
loading, it is important for stiffening the structure by holding
together the shell, preventing buckling, supporting cortical bone
in the case of impact loads and distributing loads at extremities.
Trying to discern the relative contributions of hip cortical
and trabecular bone to load bearing during locomotion and
falling using cadaveric specimens in the laboratory has been
challenging.(14–19) Differing results may to some extent reﬂect
the fact that cortical and trabecular bone structure is affected by
age and the severity of osteoporosis, with a large variation
between individuals. There are also considerable challenges in
replicating bipedal gait and hip fracture in the laboratory as wellTa
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as differences in the methods applied. Simulations involving
cadaveric hip specimens suggest that fractures involve stereo-
typical locations of the femoral cortex due to excessive focal load
concentration.(16,19,20)
Trabecular bone is also critical to hip fracture susceptibility,
with speciﬁc methods existing for the analysis of femoral
trabecular bone in vivo.(21) Because trabecular bone remodels
faster than cortical bone, the earliest effects of osteoporotic
medications are often seen in this compartment. Although we
concentrate on cortical bone in this review, it is important to
remember that trabecular density measured in the proximal
femur is often a necessary inclusion in multivariate models
predicting hip fracture or discriminating fracture from controls.
Accurate measurement of femoral microstructure (including
cortical porosity and trabecular parameters) requires much
greater resolution than is possible with clinical CT; however, it
may still be highly relevant to age‐related changes and hip
fragility.(22) Relevant discoveries on the role of bone microstruc-
ture have been reviewed in detail recently.(23)
Summary of CT Image Analysis Techniques For
the Hip
Several image analysis techniques can be used to reconstruct
and then subdivide the 3D femoral structure, permitting
measurements of density (g/cm3), mass (g), thickness (mm),
area (cm2), and volume (cm3) in cortical and trabecular
compartments of selected ROIs (traditionally the ROIs featured
in Fig. 1A). The most common are the “femoral neck” (FN),
“trochanteric” (TR), and “total hip,” similar to those used in DXA.
Several techniques further subdivide these tubular ROIs into
anatomical quadrants. Commercial and noncommercial pro-
grams are available to measure cortical bone in vivo:(24–35) we
discuss the studies reporting on these measurements. Figure 1
shows the anatomical locations of measurements reported by
different researchers. There are challenges in measuring all
of these variables from clinical CT, chieﬂy relating to the
phenomenon of partial volume averaging at low in vivo
resolution, which makes delineating cortical and trabecular
bone into deﬁnite compartments challenging. All the techniques
featured in this review have been published in peer‐reviewed
literature,(10,27–29,31–34,36–41) and some of the technical limitations
common to all the methods are described at the end of this
review.
An alternative approach to measuring traditional ROIs is to
consider the full spatial distribution of values among all subjects
through the process of statistical parametric mapping (SPM) to
identify new 3D ROIs where subjects, on average, differ from
controls.(42) This methodology has been termed “computational
anatomy,” and encompasses techniques known as voxel‐based
morphometry (VBM) for mapping 3D density values (Fig. 1E),
tensor‐based morphometry (TBM), and cortical bone mapping
(CBM) (Fig. 1F) for mapping 3D cortical thickness and
mass.(30,35,43,44)
QCT and Hip Fracture
Many studies have investigated cortical bone in the hip and its
association with hip fracture risk, providing useful information
concerning causation of hip fracture, the evaluation of hip
fracture risk, and potential targets for therapeutic and exercise
intervention. All studies have shown that cortical measurements
are associated with hip fracture, and some, but not all,
have reported that cortical measurements predict hip fracture
independently of aBMD by DXA. These studies differ in
the number of participants, study design, whether fractures
were classiﬁed into femoral neck or trochanteric (thought to be
of critical importance(3)), as well as how and where in the hip
cortical bone was measured. Generally, neither the cases nor the
controls have been optimally selected in the studies comparing
patients with existing hip fracture with controls. Cases are
problematic because the inevitable surgical repair of a hip
fracture leaves a CT image with streaking metalwork artifact on
the contralateral “good” hip, requiring instead a technically
challenging preoperative study in a patient with acutely painful
hip fracture. Not only that, but the studies of patients with
existing hip fracture (awaiting surgical ﬁxation) inevitably
involves an assumption whereby the “good hip” is uses as a
surrogate for the fractured hip. Higher resolution scanning of
controls is also problematic because the dose associated with
pelvic or hip CT (sometimes involving the gonads) would need to
be justiﬁed, meaning that controls may be selected from
“healthy” individuals who are having CT for other reasons. Only
two studies, Osteoporotic Fractures in Men (MrOS) in American
(men only) and the Age Gene/Environment Susceptibility‐
Reykjavik (AGES‐Reykjavik) study (both sexes), are truly prospec-
tive because the cohorts were assembled and imaged many
years prior to fracture. Crucially, none of the studies have
reported that cortical measurements predict fracture signiﬁcant-
ly better than femoral neck DXA aBMD values. This is not
surprising because aBMD by DXA is an amalgam measure that
encompasses elements of trabecular and cortical bone, including
cortical structure and overall bone size.
In studying Chinese womenwith andwithout hip fracture with
clinical CT, Cheng and colleagues(25) estimated cortical density
and volume in the femoral neck, trochanteric, and total hip
regions, as well as the average cortical thickness in the femoral
neck (Fig. 1D). All these cortical variables discriminated between
the 45 fracture cases and 66 younger controls; however,
trabecular density discriminated cases from controls better
than cortical density. Average cortical thickness in the femoral
neck made an independent contribution to discriminating
fractures from controls in a model including trabecular density,
but did not when the models included total hip DXA aBMD.
Using the same ROIs (Fig. 1D), the association of QCT variables
with hip fracture was explored in a prospective study of older
Americanmen from theMrOS study (3347men amongwhom 42
sustained hip fractures during follow‐up, age 65 years).(45)
Signiﬁcant predictors of hip fracture were similar to those of
Cheng and colleagues(25): cortical density in the femoral neck
was a determinant of fracture, as was cortical volume and the
percentage cortical volume (of total hip volume) when adjusted
for age, body mass index (BMI) and trial center. Independent
predictors of hip fracture risk were lower percent cortical volume,
smaller bone size (as femoral neck cross‐sectional area [CSA]),
and lower trabecular density of the femoral neck. In contrast to
Cheng and colleagues,(25) percent cortical volume and bone size
continued to make independent contributions after adjustment
for DXA aBMD. Nevertheless, overall fracture prediction was not
improved compared with DXA alone.
Yang and colleagues(46) used a different approach to perform a
QCT case‐cohort study using the same men (cohort n¼ 210,
cases n¼ 40). They calculated cortical, trabecular, and integral
density as well as cortical thickness in four quadrants of cross‐
sections along the entire length of the femoral neck,
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Fig. 1. Summary of the image analysis techniques available to measure cortical bone in vivo. Techniques in (A–D) are conventional approaches that are
based on predeﬁned regions of interest and estimates are average values over those regions.(10,27–29,31–34) Themethods differ both in the deﬁnition of ROIs
as well as how cortical and trabecular compartments are separated and how structural parameters, such as thickness, area and volume are measured.
Techniques in (E, F) are computational anatomical methods that consider the whole structure to identify ROIs using statistical parametricmapping.(30,35,43–
44) These procedures allow researchers to determine if there is a statistically signiﬁcantmean difference betweengroups (orwith time, with treatment, with
placebo, etc.) and to show the site(s) and magnitude of those differences on a femur model. The results from these methods are usually visualized with
feature maps. The colorized scale usually represents the values themselves but separate maps of t values or p values can also be generated. (A) ROIs as
deﬁned byMIAF‐Femur software. Cortical (and subcortical) density, thickness, area and volume are measured in three regions: FN, TR (greater trochanter),
and IT (includes a half of the lesser trochanter). (B) ROIs as deﬁned byMindways software. Cortical density, thickness, and area aremeasured in four regions:
FN, TR (greater trochanter), IT (including the lesser trochanter) and total proximal femur that comprising all three regions. An additional module (BIT2)
allows further subdivision of the FN region into anatomical quadrants (cross‐section inset). (C) ROIs as deﬁned by Yang and colleagues. Cortical density and
thickness measured in four regions: FN, TR (greater trochanter), TR (including lesser trochanter) and total proximal femur comprising all regions. In
addition, each cross‐section (FN, IT, and TR) can be further subdivided into anatomical quadrants (cross‐section insets). (D) ROIs as deﬁned by Lang and
colleagues, whomeasured cortical density, thickness, area and volume in three regions: FN, TR (encompassing the greater and lesser trochanters) and total
proximal femur comprising both. (E) This map shows a mid‐coronal cross section of a t‐map generated using voxel based morphometry (VBM), where
nonsigniﬁcant voxels have been rendered transparent and signiﬁcant voxels assigned a degree of opacity based on their t values. The map displays
differences in vBMD between younger and older American women (adapted from(35)). (F) A color map displaying the average percentage difference in
cortical thickness between women with femoral neck fracture and age‐matched controls. ROI identiﬁcation using cortical bone mapping involves
registration of 3D cortical bone maps to an average femur surface followed by multivariate modeling using Surfstat software (adapted from(43)).
FN¼ femoral neck; TR¼ trochanter; IT¼ intertrochanter; SA¼ superoanterior; SP¼ superoposterior; IA¼ inferoanterior; IP¼ inferoposterior; MA¼
medioanterior; LA¼ lateroanterior; MP¼medioposterior.
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intertrochanteric, and trochanteric ROIs (Fig. 1C). In most
quadrants, density and thickness were signiﬁcantly lower in
cases compared to the subcohort. They also merged quadrants
into simple lateral and medial halves of the femoral neck
(superior and inferior respectively), plus trochanteric (lateral and
medial) for discrimination analyses. Lower cortical density and
thickness in all regions was signiﬁcantly associated with hip
fracture except cortical density of the inferior neck. Once again,
cortical measurements did not predict hip fracture indepen-
dently of total hip DXA aBMD; interestingly, trabecular density of
the femoral neck and medial trochanteric regions did. The
regression model combining age, total hip DXA aBMD, and
trabecular density best predicted hip fracture (area under the
receiver operating characteristic curve [AUC] of 0.901, 95%
conﬁdence interval [CI] of 0.852–0.950). It should be noted that
there were relatively few hip fractures in comparison with the
number of variables and further study of this large and unique
cohort is needed. More recently, Yang and colleagues(47)
identiﬁed deﬁcits in bone density and cortical thickness
throughout the proximal femurs of 50 British postmenopausal
women comparedwith controls in amatched case‐control study.
Cortical thickness and density discriminated fracture cases from
controls independently of DXA aBMD, although substantial
changes in bone parameters may have occurred in the 3 weeks
to 3 months between fracture and CT assessment.
The AGES‐Reykjavik study is a single‐center prospective
population study of Icelandic men and women with baseline
CT of 5500 individuals obtained between 2002 and 2006. In a
prospective analysis of a subset from this cohort, QCT analysis of
themid‐femoral neck (Fig. 1B) was performed tomeasure cortical
thickness in different regions and to predict incident femoral
neck and trochanteric fracture in a case‐control analysis. Fifty‐ﬁve
men were included who subsequently fractured (31 FN, 24 TR)
versus 111 age‐matched male controls, and 88 women with hip
fracture (47 FN, 41 TR) versus 187 female controls.(48) Cortical
thickness estimated in the superior region of the femoral neck
was a stronger predictor for hip fracture than the inferior region
in both sexes. There were signiﬁcant gender differences in
cortical thickness measurements in the control group but not in
the case group, implying that the mechanism causing bone
thinning in “at risk” individuals might be similar in men and
women. Cortical thickness estimated in the superoanterior
quadrant (SA; Fig. 1B) was the best discriminator of cases from
controls. Trochanteric fracture cases were thinner in the inferior
neck than femoral neck cases. In multivariate analysis for the risk
of femoral neck fracture, SA quadrant cortical thickness was
important in both women and men, and remained a signiﬁcant
predictor after adjustment for femoral neck DXA‐like aBMD. In
those men who sustained trochanteric fracture, both cortical
thickness and total hip DXA‐like aBMD made independent
contributions to fracture prediction. The results from this study
suggest that cortical thinning superiorly in the hip might be of
importance in determining resistance to femoral neck fracture, as
predicted from extensive preclinical studies.(49)
French and Englishwomen (age60 years) were recruited to a
QCT hip fracture case‐control study involving 47 women with
fracture (24 FN, 23 TR) and 60 controls (Fig. 1A).(50) Cortical
thickness and trabecular density were again independent
predictors of hip fracture risk. Average cortical thickness was
signiﬁcantly lower in the femoral neck, trochanteric, and
intertrochanteric ROIs in the hip fracture group. Only in the
trochanteric ROI were cortical density and cortical volume
signiﬁcantly lower in fracture cases, whereas trabecular (and
integral) density measurements were signiﬁcantly lower in all
ROIs in the hip fracture group. Once more, overall hip fracture
discrimination was not improved compared to DXA aBMD. Using
logistic procedures to discriminate fractures from QCT measures
only, the authors found that a model combining trochanteric
trabecular density and mean trochanteric cortical thickness
provided the best discrimination of trochanteric fractures
from controls, whereas the best discriminator for femoral neck
fractures was trabecular bone density in the femoral head.
However, the sample size was relatively small for the
discrimination of fracture types.(50)
Concerning themid‐femoral neck (Fig. 1B, but using the center
of mineral mass to divide sectors rather than center of area),
two small case‐control studies were carried out to investigate
determinants of trochanteric (n¼ 16) and femoral neck fracture
(n¼ 20) among elderly Japanese women.(26) No differences
were found in trabecular density between the controls and
fracture cases. Instead, both fracture groups had lower cortical
density, bone size, a larger medullary area, and a thinner cortex
compared to controls. Thus there may be important differences
between populations and fracture types in the structural
determinants of hip fracture.
Moving to SPM methodology using VBM, two QCT case‐
control studies (one of Chinese women, one of Icelandic women)
were used to identify the location, magnitude and statistical
signiﬁcance of mean differences between groups with and
without fracture.(30,35) SPM was used ﬁrst on hip CT data by
application to the nonfractured hip of 37 fracture cases and 38
age‐matched controls in Chinese women, with results showing
that density differences were not uniformly distributed.(30) The
main differences were actually localized in three new ROIs:
medially and superiorly in the femoral head, superiorly in the
femoral neck, and inside the trochanter. In a later, larger study,
analysis was done in a group of older women from the Icelandic
AGES study with (n¼ 74) and without (n¼ 148) incident hip
fracture 4 to 7 years after their baseline CT scans.(35) SPM showed
that women who fractured their hips had relative deﬁcits in the
superior cortex, in trabecular bone regions, as well as in the
inferior aspect of the femoral neck and the intertrochanteric
region. Even though the mechanical implications of these
differences are somewhat conjectural, these foci of bone loss
coincide with the locations of highest stresses in a sideways
simulated fall conﬁguration and the least loaded locations in a
stance conﬁguration.(17) Recently, this study has been reanalyzed
to include the effects of shape variation in addition to density
distribution in TBM, a modiﬁcation of VBM.(44)
A further CT study of women from the Czech Republic used
CBM to examine cortical thickness over the entire proximal
femoral cortex to identify and visualize surface ROIs where cases
and controls differed signiﬁcantly.(43) Seventy‐ﬁve women with
acute hip fracture (36 FN, 39 TR) were compared with 75 age‐
matched and sex‐matched controls, the results showing a
marked phenotypic difference between the hips of patients
sustaining the two hip fracture types. The femoral neck fracture
cases had a thumbnail sized patch of 30% thinner cortex at the
superoanterior femoral neck (Fig. 1F), which was not apparent in
the trochanteric fracture cases, conﬁrming the importance of this
zone.(48) Cases who had sustained a trochanteric fracture had
a thinner cortex on the trochanter compared to controls. The
similarities in location of the ROIs using SPM and traditional
femoral neck ROIs are notable,(30,35,43,48) but sensitivity analyses
are awaited to establish the ability of VBM and CBM to predict
incident fracture.
776 JOHANNESDOTTIR ET AL. Journal of Bone and Mineral Research
The studies discussed above have conﬁrmed that QCT‐derived
measurements of the hip cortex are strongly related to hip
fracture risk and can provide useful information concerning
causation of hip fracture. Parametric methods have generated
new targets for treatment: ROIs that differ between those with
fracture and those without. Whereas VBM‐derived ROIs appeared
to improve speciﬁcity for hip fracture discrimination in receiver
operating characteristic (ROC) analysis compared to traditional
ROIs (at a ﬁxed 95% sensitivity),(30) it is worth noting that any QCT
technique has yet to outperform DXA aBMD in hip fracture
prediction, and a subsequent article from the same team made
no reference to comparative fracture discrimination.(35)
Sex Differences Identified From Hip QCT
There is an exponential increase in hip fractures from age 50 to
100 in both sexes, but the rates observed in elderly women are
approximately double those observed in elderly men.(51) One
reason for thismight be differences between the sexes in femoral
bone structure that persist throughout life. Figure 2 describes
some of these differences, as well as ageing differences identiﬁed
in QCT studies.
Riggs and colleagues(52) examined a single cross‐section of the
mid‐femoral neck in a cohort of U.S. men (n¼ 323) and women
(n¼ 373) from 20 to 90 years old who had undergone hip QCT.
Hip scans were examined by applying in‐house scripts.(39)
The femoral neck CSA of young men (aged 20–29 years) were
one‐third larger on average than women of the same age, with
higher cortical density. Differences were maintained into old
age.(53) Similar sex differences were observed in older Icelandic
individuals among a large population‐based cohort of 1715 older
Icelandic individuals aged 67 to 93 years (807 men, 908 women)
examined as in Fig. 1D.(53) In the age group of 67 to 69 years, men
had persistently larger femoral neck size (eg, 32% larger minimal
CSA) and thicker cortices (9% thicker at the FN region and 11% at
the TR region) compared to women.(53) It is worth highlighting
that whereas FN cortical density was similar in both sexes (and
only slightly lower among women in the TR region), women had
substantially lower trabecular density throughout the hip ROIs.
Figure 2 illustrates that a proximal femur of a typical older female
(aged 65 years) has few remaining trabeculae in the greater
trochanter, which can appear to be empty of medullary bone—
this is a consistent ﬁnding.(52,53) Although Icelandic men had
thicker cortices than women overall, one zone where the sexes
did not differ in cortical thickness was at the inferoanterior
femoral neck (Fig. 1B), a region highly loaded during walking
throughout life.(48,54) In a related longitudinal study of older
Icelandic adults (100 men and 300 women, mean age 74 years)
cortical density of the superior FN region was greater in the men
but there was no sex difference in the inferior FN region at
either baseline or follow‐up.(54) This zone was also relatively
protected from age‐related bone loss in a cross‐sectional
study of British women aged 20 to 90 years.(31) The assumption
that has beenmade is that loading of the inferior neck bywalking
helps preserve this zone from age‐related bone loss in both
sexes.
With advancing age, endocortical and intracortical remodeling
increase, to result in cortical bone that becomes thinner and
more porous.(31,48,55,56) It has been hypothesized that endosteal
bone loss precedes periosteal apposition,(57) which adapts to
maintain whole‐bone strength.(58) In addition, some studies
using DXA indicate that men undergo a pattern of favorable
periosteal apposition to a greater extent than women and that
this may contribute to their lower fracture rate.(59–62) However,
others using QCT have reported that women exhibit similar
periosteal apposition to men.(52,53) It is unclear whether
periosteal apposition continues into old age. Kaptoge and
colleagues(63) found with DXA that the width of the elderly
femoral neck in the anteroposterior projection gradually
increased over time. However, in the only two genuinely
prospective studies using 3D CT, the size of the femoral neck
was unchanged over a follow‐up period of 2 and 5 years
(Fig. 1B).(54,64) In a cross‐sectional study, Nicks and colleagues(65)
reported that total bone volume measured at different locations
in the hip increased from a group of younger to older
premenopausal women but not from premenopausal to
postmenopausal women (Fig. 1A). In the MrOS study, the
femoral neck size was minimally related to age in men.(66) Age
was also associated with increasing femoral neck size in the
cross‐sectional AGES study by about 2% per decade in both men
and women(53) (Fig. 1D). In a small subset from the same cohort
(48 men and 59 women) the expansion primarily occurred in the
superior to inferior directions.(67) The cross‐sectional nature of
some of these studies might have introduced secular trends.
Clearly there is a need for prospective studies over longer time
periods in both sexes.
Changes in Proximal Femoral Cortical Bone With
Advancing Age
The ability of cortical bone to resist fracture deteriorates
with aging in both men and women. Several studies have
examined the effect of aging on cortical bone in the hip with a
cross‐sectional study design, whereas two studies have been
prospective.
A cross‐sectional population‐based QCT study of American
men (n¼ 323) and women (n¼ 373) in the age range 20 to
90 years indicated that elderly hips were larger than young hips,
with a larger medullary area and lower cortical area.(52) Cortical
bone density was 24% lower in elderly women and 13% lower in
elderly men than younger subjects in the cohort. Nicks and
colleagues(65) investigated the samewomen inmore detail using
a different method (Fig. 1A), conﬁrming that there was little
cortical bone loss in the proximal femur of premenopausal
women, but there was signiﬁcant loss in postmenopausal
women. Most striking in these studies were the different
trajectories of bone loss, with cortical bone loss beginning in
mid‐life, whereas trabecular bone loss was lifelong. In a smaller
cross‐sectional study of 100 British women, femoral neck
cortical bone loss did not show the same initiation phase in
mid‐life; the decline was apparently linear from 20 to 90 years
(Fig. 1B).(31)
Age‐related changes in bone are not just conﬁned to the
femoral neck, but nor are they conﬁned to the cortical
compartment. In a cross‐sectional study of 908 Icelandic women
aged 67 to 93 years, cortical density decreased at both the
femoral neck and trochanter among women, but the relative
decrement in cortical thickness was greater (Fig. 1D).(53)
Comparing cortical density with thickness, a cross‐sectional
study of 107 British and French women aged 60 years (Fig. 1A)
demonstrated that cortical density declined with aging, but only
in the trochanteric region, whereas cortical thickness decreased
signiﬁcantly with age in the neck, trochanteric, and intertrochan-
teric regions.(50)
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In both sexes, cortical bone distribution is asymmetric in the
femoral neck. Returning to the cross‐sectional study of 100
British women, even young women had a much thicker inferior
than superior cortex. This asymmetry persisted in the old, as
illustrated in the femoral neck cross‐sections of Fig. 2A–C.
However, by the ninth decade the femoral neck appears
strikingly thinner in the superior cortex, but with relative
preservation of the inferior cortex.(31) These results conﬁrm
earlier cadaveric studies.(49,68,69) Even among older individuals
studied prospectively, superior bone loss continues in both
sexes, but at a rate twofold higher in women. Four hundred older
Icelandic individuals from the AGES study had CT scans at
baseline and 5 years later (100 men and 300 women, aged 66–90
years) (Fig. 1B). The principal ﬁnding was that, even among older
men and women, cortical bone loss in the superior region of
the femoral neck was approximately threefold greater than
inferior bone loss and the pattern of loss in trabecular bone was
similar.(54) Among women, the decline in cortical thickness and
density of the superior half of the femoral neck averaged 3.3%
per year and 1.2% per year, respectively, contrasting with losses
of 0.9% per year and 0.4% per year respectively in the inferior
femoral neck. In that study, ROIs were deﬁned by merging
superior quadrants (SP and SA) into a “superolateral” half and
inferior quadrants (IP and IA) into an “inferomedial” half (Fig. 1B).
It is noteworthy that a prospective study was needed to
demonstrate femoral neck cortical bone loss inmen, with several
earlier cross‐sectional studies of men from the same cohort
indicating no age‐associated differences in the male FN region
cortex.(48,53) The prospective results in Icelandic men are,
however, in keeping with a large cross‐sectional study of
American men (n¼ 3358, aged 65–100 years).(66) Marshall and
colleagues(66) found that the oldest men (85þ years) had 5%
less cortex and 10% larger medullary volume at the femoral
neck compared with the youngest in the study (65–69 years)
(Fig. 1D).
It is important to note that most of these studies have been
conducted in whites, yet substantial ethnic variation in bone
structure occurs, with American black and Asian men having
thicker cortices with higher trabecular density than American
white men.(70) Studies of aging in men and women of different
ethnicities are needed, particularly given the rising incidence of
hip fracture in Asia. One prospective study of 59 Japanese
women (aged 54–84 years) followed for 2 years has been con-
ducted (Fig. 1B): cortical thickness in the femoral neck decreased
by 1.1% per year, but cortical density was unchanged.(64) One
published study and one study in abstract form have examined
aging effects using SPM. American women (n¼ 349) were
included in a study of age‐related bone differences that used
intersubject image registration and VBM.(35) Groupswere divided
into young (age <45 years, n¼ 94), middle‐age (45 age <60
years, n¼ 98), and older women (age 60 years, n¼ 157). The
results conﬁrmed the sharp progression of bone loss in the
superior cortex of the femoral neck, but also in the trabecular
bone of the FN and TR regions (Fig. 1E). These results indicated
that bone was largely preserved along the trajectories of high
load during locomotion (stance) and lost in regions of low load as
deﬁned in ﬁnite element (FE) studies simulating a stance
conﬁguration.(71) Studying 268 British women aged 53 to
93 years, Treece and colleagues(72) found a similar pattern of
cortical mass preservation with age using CBM. These tools give
researchers the ability to examine drug and exercise effects, with
the aim of investigating whether interventions can preserve
bone in the unloaded as well as loaded areas.
The Effect of Drug Treatment on Cortical
Bone in the Hip
In the previous sections we have highlighted speciﬁc defects
present in the femurs of older people who go on to fracture their
Fig. 2. Some of the major sex and aging differences identiﬁed in QCT
studies. (A–C) Representative female hips from three different age
groups. These 3D models of cadaveric hips were made using mCT;
mid‐coronal cross‐section and cross‐section through femoral neck of: (A)
a 40‐year‐old woman; (B) a 66‐year‐old woman; and (C) a 77‐year‐old
woman, respectively. (A) Among adults (age range c.20 to 64 years): (1)
the superolateral femoral neck cortex is half as thick as the inferomedial
cortex in both sexes(31,68); (2) there is a similar average femoral neck
cortical thickness in both sexes(52); and (3) themale femoral neck remains
one‐third larger in cross‐sectional area than in women throughout
life.(52,53) (B–C) Among older adults (age range65 years) of both sexes:
(1) the superolateral cortex shows three times faster thinning with aging
than the inferomedial cortex(54); (2) women have two times faster cortical
thinning with aging than men(54); (3) the weight‐loaded inferomedial
cortex is preserved in both sexes(31,35,54); (4) only one‐half of young adult
trabecular bone density remains in the very old(31,52); and (5) very oldmen
have 10% larger femoral neck medullary area and 5% less cortical bone
than old men.(66) The femurs were courtesy of the Melbourne Femur
Collection, Chairman Professor John Clement (Melbourne Dental School).
Trafﬁc sign images are UK crown copyright.
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hips, some of which coincide with age‐related changes. Here we
review the effects of drugs on these speciﬁc QCTmeasures. Older
women with osteoporotic fractures or low DXA aBMD have
been enrolled in large randomized controlled trials (RCTs) to
demonstrate the efﬁcacy of antiosteoporotic drugs. Although
few hip fractures occurred in these trials, older women
randomized to receive alendronate, risedronate, zoledronate,
and denosumab had approximately one‐half as many hip
fractures as those receiving placebo.(73) Surprisingly little is
known about how these drugs prevent hip fractures. Plotting the
events by group for each trial, it is notable that fracture rates
diverge then appear to run in parallel; in other words there is a
fairly early prevention of fracture, and then a gradual increase in
hip fractures in both groups at a similar rate. Could strengthening
of speciﬁc hip defects be the explanation for the fairly rapid
prevention of fractures with these drugs? Or among a population
of women already selected for their fragile bones, do the
drugs have focal effects on weak areas, preventing fractures
that occur spontaneously, or during trips and stumbles?(4,74)
The prevention of fractures cannot be fully explained by
enhancement in DXA aBMD, so we turn to studies using QCT
for possible answers.
The effects of bisphosphonate treatments such as alendronate
(ALD), risedronate (RIS), zoledronic acid (ZOL), and ibandronate
(IBD) are to decrease osteoclastic resorption, and hence decrease
the rate of bone turnover, whereas anabolic treatments such as
parathyroid hormone (PTH) and teriparatide (TPTD) stimulate
bone remodeling and ultimately bone formation. Increasingly,
new drug trials have included smaller substudies involving serial
clinical CT in order to investigate the effect of these drugs at
the hip.
We have to rely on comparator studies to examine the effects
of alendronate. Black and colleagues(75) evaluated the effects of
PTH and ALD alone and in combination using hip QCT (Fig. 1D)
among postmenopausal women with osteoporosis (aged 55–85
years). Women were randomized to daily full‐length PTH (1–84,
n¼ 119 women), ALD (10mg/d, n¼ 60), or both (n¼ 59) and
were followed for 12 months. Trabecular density increased
signiﬁcantly within all treatment groups but with no signiﬁcant
difference between groups. Total hip cortical density increased
by 1.2% with ALD, whereas it decreased by 1.7% with PTH
treatment and was unchanged with combination. The study was
then extended for a further year, after which cortical density had
decreased by 2% to 3% from baseline with ALD; the same was
seen with PTH and placebo, and PTH given for 2 years.(76)
Conversely, with combination PTH plus ALD for 1 year followed
byALD in the second year, cortical density wasmaintained. Given
the expected mechanism of action of ALD, a surprising ﬁnding
was that cortical volume appeared to increase slightly during
ALD therapy, although less than was seen with PTH alone. This
might signify that with ALD treatment, a greater proportion of
endocortical “trabecular” voxels became classiﬁed as “cortical”
voxels when using an analysis technique based on thresholding.
A randomized double‐blind study conducted by McClung
and colleagues(77) compared the effect of ALD (10mg/d,
n¼ 30) versus TPTD (20mg/d, n¼ 26) in postmenopausal women
with osteoporosis. Cortical density in the FN region (Fig. 1B)
was signiﬁcantly different between ALD and TPTD groups,
increased by 7.7% in ALD group, and decreased by 1.2% in TPTD
group.
The effect of once‐yearly zoledronic acid (5mg intravenously
[iv] per annum) on hip QCT parameters (Fig. 1A) was examined by
Eastell and colleagues(78) in a subset of postmenopausal women
(ZOL, n¼ 93; placebo, n¼ 86) from the large HORIZON‐PFT RCT.
Over 3 years of treatment, ZOL increased total and trabecular hip
density versus placebo. Cortical density did not differ signiﬁ-
cantly between groups but cortical bone volume in the total hip
and TR ROIs increased (7% and 9%, respectively) in the treatment
group versus placebo, a similar ﬁnding to that reported by Black
and colleagues(75) studying the effects of ALD. Yang and
colleagues(79) used the same HORIZON‐PFT substudy data to
further divide up the various traditional ROIs into more than 24
individual hip QCT parameters (using a slightly modiﬁed version
of Fig. 1C, with different ROI boundary deﬁnitions and names).
Statistical correction for multiple comparisons was not described
in the paper, but percentage improvements in overall femoral
neck density were mostly seen in the superior quadrants.
Interestingly, percentage improvements were greater in trabec-
ular than cortical bone of the same region. In fact, the most
consistent QCT response variable across the range of anti-
resorptive trials has been trabecular density.
Although ibandronate has not been proven to prevent hip
fractures, its effects on hip QCT parameters were studied during
1 year of therapy in a double‐blind RCT versus placebo (women
aged 55–80 years, IBD 150mg by mouth [po] once monthly
n¼ 39, placebo n¼ 32).(80) The traditional cortical bone ROIs
(Fig. 1A) did not show signiﬁcant changes in any region.
However, in a post hoc analysis using the same data which now
combined the subcortical and cortical ROIs, IBD increased the
density by 1.5% in the total hip “extended ROI” and 2.4% in the
trochanteric “extended ROI” versus placebo.(81) Once again,
monthly oral IDB for 12months improved trabecular density in all
the extended ROIs versus placebo.
One drug licensed for treating osteoporosis in Japan is an
analogue of active vitamin D, eldecalcitol (ELD). Although the
drug has not been shown to reduce hip fractures, osteoporotic
women receiving ELD have been subject to serial hip QCT
analysis in comparison with another licensed active vitamin D
analogue alfaclacidol (ALF) (Fig. 1B).(82) Here the principal ﬁnding
was that ELD maintained cortical thickness and “total hip”
density, despite a decrease in trabecular density of about 4%.
By contrast, ALF treated women lost cortical thickness and
“total hip” density, as well as an approximate 7.5% decrease in
trabecular density. Cortical mass and density did increase with
both treatments.
Neither TPTD nor PTH (1–84) have been shown to prevent hip
fracture in RCTs, although Black and colleagues(75,76) did show
that hip cortical density decreased over 1 and 2 years of PTH
treatment. Although cortical bone volume increased by 4.4%
when 1 year of PTHwas followed by ALD, it did not when the PTH
year was followed by placebo. McClung and colleagues(77) also
discovered that cortical density decreased by 1.2% from baseline
to 18months with TPTD, although there was a greater increase in
trabecular density with TPTD than with ALD. Keaveny and
colleagues(83) found similar results, including a 6.2% reduction in
cortical mass with PTH among the same trial participants as in
Black and colleagues.(75,76) Borggrefe and colleagues(84) used
serial hip QCT scans to perform a segmental femoral neck
analysis (Fig. 1B) of 52 postmenopausal women (aged55 years)
with severe osteoporosis treated with TPTD (20mg/d). Cortical
density declined by 2% after 2 years treatment whereas
cortical mineral content and cortical cross sectional area
increased by 2.3% and 4.3%, respectively. Total area was
unchanged during follow‐up. These studies suggest that PTH
treatment stimulates endocortical and cortical bone growth, but
decreasing cortical density indicates that the new cortical bone is
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less packed with mineral (ie, new bone) and/or more porous.
Follow on therapy with antiresorptives seems necessary for
optimal effects.
Analysis of the same trial participants as in Borggrefe and
colleagues(84) given TPTD for 2 years revealed that cortical
thickness increased by up to 12% over large areas of the hip,(33)
including several sites of focally low bone thickness and mass
that were previously identiﬁed in women with hip fracture.(33,43)
However, cortical mass only increased signiﬁcantly in a very small
intertrochanteric area.(33) These results contrast with the striking
effects of the antiresorptive denosumab on cortical mass, shown
using a range of techniques (Fig. 1A, B; CBM).(85–87) In a subset of
postmenopausal women from the FREEDOM trial who received
60mg of denosumab versus placebo every 6 months for 3 years,
denosumab‐treated women showed a progressive increase in
cortical mass and thickness over time.(88) As was seen with
bisphosphonates, the relative improvements were greatest in
the trabecular compartment.(85,87) Cortical mass increased
almost throughout the hip, being associated with smaller
magnitude cortical thickening (which is believed to represent
the inﬁlling of cortical and endocortical pores in the early phase
of treatment).(85,88) Odanacatib is an inhibitor of cathepsin K and
has been investigated in two recent studies.(89,90) After 2 years,
Brixen and colleagues(89) found that trabecular (but not cortical
density) differed signiﬁcantly between odanacatib and placebo
in the hip. Cortical thickness of the mid‐femoral neck increased
with treatment but decreased with placebo. In a smaller study by
Engelke and colleagues,(90) odanacatib effects were compared
with placebo or ALD treatment. In contrast to the results of Brixen
and colleagues,(89) odanacatib increased both trabecular and
cortical density at the hip but had no effect on cortical thickness.
The changes in cortical and trabecular density were similar in the
ALD and odanacatib groups.
It remains to be seen which of cortical mass, cortical volume,
cortical thickness, or trabecular parameters are more important
in preventing hip fracture. The best evidence to date comes from
the large trials of antiresorptives, which mostly enhance bone
mass, because no hip fracture end‐point trials have been
conducted with TPTD or PTH. However, absence of evidence
should not preclude further efforts toward preventing hip
fracture with anabolic compounds. The results from QCT hip
studies, particularly those including sequential antiresorptives
after anabolic drugs, are very encouraging.
Limitations
There have been numerous technical approaches to try and
overcome the inherent inaccuracies involved in measuring thin
cortical bone using clinical QCT. The spatial resolution of the CT
scanners is limited such that measurements may be under‐ or
overestimated because of trabecular bone adjacent to the
endosteal surface or soft tissue adjacent to the periosteal surface.
Both in‐plane resolution and slice thickness cause partial volume
artifacts that affect cortical measurements.(38,91–93) Because the
femoral neck is oriented obliquely to the scan plane it is affected
more than other regions, although one of the techniques takes
this into account.(32,33) A cortical thickness of 2 to 2.5mm is
generally required for accurate cortical density evaluation in
clinical CT,(91) whereas cortical density values below this
threshold are typically a function of the cortical thickness and
cortical porosity because of partial volume averaging. Thismeans
that a thin structure will appear to have lower density and less
accurate thickness. The partial volume effect tends to make
trabecular bone close to the endosteal boundary appear more
dense and cortical bone less dense than they really are.(38,94)
Despite these limitations, cortical bone measurements are
associated with hip fracture in many studies, and whereas
cortical density and thickness measurements are challenging,
changes in these variables can be detected more accurately
when the difference exceeds a certain threshold.(93) Although
the techniques that we have reviewed differ in how cortical bone
and trabecular bone are delineated (as well as in the location and
method of measurements), no studies directly comparing the
methodologies have been reported. Despite this, the major
conclusions from the clinical studies are remarkably consistent,
whichever methods have been applied.
Conclusion
Clinical QCT studies of the hips have led to a greater
understanding of the patterns of bone loss associated with hip
fracture, age‐related changes, and the effects of drugs used to
treat osteoporosis. From these studies, particular regions of the
proximal femoral cortex have been identiﬁed, not only as sites
relevant to fracture causation, but also as sites which are novel
targets for therapeutic and other interventions. Results fromQCT
studies of “traditional” ROIs and those derived from parametric
methods (SPM and VBM) seem to agree, largely on where the
critical changes associated with ageing and hip fracture occur.
However, it is not yet known whether these CT‐derived bone
measurements will improve fracture prediction compared with
existing clinical techniques, and further prospective studies are
awaited. It is also worth remembering that cortical bone,
although of crucial importance in determining hip fracture and
treatment response, is one of many variables which need to be
considered in efforts to understand and prevent the burden of
age‐related hip fractures. The advances in clinical CT imaging
and image processing that we have reviewed here continue to
play a key role in meeting this challenge.
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